Form 4: GE HealthCare Director Phoebe L. Yang Watkin Acquires Restricted Stock Units

Director Phoebe L. Yang Watkin acquired 2,440 restricted stock units of GE HealthCare Technologies Inc. on May 21, 2024.

Summary

• On May 21, 2024, Phoebe L. Yang Watkin, a director of GE HealthCare Technologies Inc., acquired 2,440 restricted stock units.
• These restricted stock units will vest on the earlier of GE HealthCare's next annual meeting of stockholders or May 21, 2025.
• Each restricted stock unit represents the right to receive one share of GE HealthCare common stock at settlement.
• Following the transaction, Ms. Yang Watkin directly owns 6,024 shares of GE HealthCare common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of restricted stock units by a director is generally seen as a positive sign, indicating confidence in the company's future. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of restricted stock units by a director signals confidence in the company's future performance.
• The vesting schedule aligns the director's interests with those of the shareholders, encouraging long-term value creation.

Future Outlook

The restricted stock units will vest on the earlier of GE HealthCare's next annual meeting of stockholders or May 21, 2025, aligning the director's interests with the company's performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, ensuring fair market practices.

Stakeholder Impact

• The acquisition of restricted stock units by a director can positively influence shareholder sentiment, as it aligns the director's interests with the company's long-term success.

Key Dates